Benefit of the Sequential Administration of Docetaxel after Standard FEC Regimen for Node-Positive Breast Cancer: Long-Term Follow-Up Results of the FNCLCC-PACS 01 Trial.
暂无分享，去创建一个
T. Delozier | M. Campone | T. Petit | J. Canon | G. Romieu | G. Jerusalem | Anne-Laure Martin | M. Spielmann | P. Chollet | M. Beauduin | B. Audhuy | D. Serin | H. Roché | M. Symann | C. Veyret | H. Orfeuvre | J. Eymard | B. Coudert | F. Eichler | G. Piot | D. Serin | Gilles Piot | M. Beauduin